The foundation of SpectraCann’s products is based on direct absorption spectroscopy, offering significant advantages over conventional chemistry lab tests. Unlike traditional methods that often require chemical reagents, sample preparation, or lengthy procedures, direct absorption spectroscopy provides real-time, non-invasive detection of specific molecules. It is highly sensitive, allowing for the detection of trace compounds at extremely low concentrations and enabling multi-chemical detection from just one sample.
An all-in-one solution that facilitates testing anywhere, anytime.
Join Our THC Breathalyzer Pilot Program
Participate in our pilot program and contribute to safer workplaces and communities. We’re seeking organizations interested in evaluating our technology and providing feedback on their experience.
Collaborate With Us
We invite companies to submit a Letter of Intent (LOI) for collaboration on our novel THC breathalyzer technology, revolutionizing drug detection and public safety.
At the forefront of innovation in drug, substance, and biomarker detection, our advanced solutions offer unprecedented accuracy, speed, and versatility across various applications from workplace safety, and law enforcement to homeland security and healthcare – and beyond.
SpectraCann’s technology rapidly identifies trace amounts of illicit drugs such as THC, opioids, and synthetic substances in the breath, ensuring safety in environments with zero tolerance policies.
Our versatile system can detect substances and drugs like fentanyl, meth and cannabis in the air with unmatched precision. This application supports law enforcement, security and public safety.
With applications in healthcare, our technology enables early detection of diseases and metabolic conditions by analyzing specific biomarkers in breath, revolutionizing preventive medicine.